ArticleFrontiers in oncology2021

Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia.

Fu-Jia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.